Cambiar Investors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-331,767
Closed -$4.96M 166
2025
Q1
$4.96M Buy
331,767
+22,557
+7% +$400K 0.21% 93
2024
Q4
$5.87M Sell
309,210
-31,024
-9% -$656K 0.23% 91
2024
Q3
$9.21M Buy
340,234
+10,862
+3% +$277K 0.35% 84
2024
Q2
$8.2M Sell
329,372
-4,908
-1% -$141K 0.32% 87
2024
Q1
$11.1M Buy
334,280
+10,848
+3% +$371K 0.41% 85
2023
Q4
$11.5M Buy
323,432
+42,685
+15% +$1.35M 0.45% 74
2023
Q3
$9.59M Buy
280,747
+8,201
+3% +$312K 0.41% 82
2023
Q2
$10.9M Buy
272,546
+21,901
+9% +$871K 0.46% 69
2023
Q1
$9.85M Buy
+250,645
New +$9.2M 0.42% 69

Other funds holding XRAY

Cambiar Investors's XRAY Position: Q2 2025 in Review

Cambiar Investors sold out of Dentsply Sirona (XRAY) in Q2 2025, closing a stake of 331,767 shares — an estimated $4.96M sold.

Cambiar Investors first reported a position in XRAY in Q1 2023 and held it in 9 quarters. The position peaked at $11.5M in Q4 2023. 392 funds tracked by Wall St. Rank hold XRAY as of Q2 2025.

  • Cambiar Investors reported no remaining Dentsply Sirona position as of Q2 2025 after selling out during the quarter.
  • Cambiar Investors sold 331,767 Dentsply Sirona shares in Q2 2025, an estimated $4.96M.
  • Cambiar Investors first reported a position in Dentsply Sirona in Q1 2023 and held it in 9 quarters.
  • Cambiar Investors's Dentsply Sirona position peaked at $11.5M in Q4 2023.
  • 392 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2025.

Based on Cambiar Investors's 13F filing for Q2 2025, filed 5 Aug 2025.